Hisamitsu Pharmaceutical Co.; Inc.;HISAMITSU PHARMACEUTICAL CO INC
发明人:
申请号：
EP06714872.6
公开号：
EP1857103B1
申请日:
2006.02.28
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
A transdermally absorbable preparation that even when a drug with poor solubility in a base is added in high concentration, is stable over time and can suppress crystallization of the drug, excelling in transdermal absorbability. There is provided a transdermally absorbable preparation, comprising a base and, added thereto, at least composite particles which are composed of a silicate compound and an organic acid and a drug.
